Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.

Neurology and therapy·2026
Same author

Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.

The Lancet. Neurology·2026
Same author

Association of Acute Ischemic Stroke Volume With Post-Stroke Epilepsy Development.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026
Same author

Overlapping features of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome.

Journal of the neurological sciences·2026
Same journal

Patterns of psychological resilience and social avoidance among the patients of Neuromyelitis Optica Spectrum Disease: a latent profile analysis.

Multiple sclerosis and related disorders·2026
Same journal

Discontinuation of disease-modifying therapies in patients with multiple sclerosis: A retrospective case-control study.

Multiple sclerosis and related disorders·2026
Same journal

Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same journal

Comparative immunopathology and clinical features of MOGAD and AQP4-IgG NMOSD in children: A scoping review.

Multiple sclerosis and related disorders·2026
Same journal

Self-perception of speech impairment in MS: Associations with dysarthria severity and speech measures.

Multiple sclerosis and related disorders·2026
Same journal

Taking progressive biology seriously in the time of B-cells and BTK.

Multiple sclerosis and related disorders·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Differentiating multiple sclerosis from non-specific white matter changes using a convolutional neural network image

Moein Amin1, Kunio Nakamura2, Daniel Ontaneda1

  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Multiple Sclerosis and Related Disorders
|January 6, 2024
PubMed
Summary
This summary is machine-generated.

Machine learning models can differentiate multiple sclerosis (MS) from non-specific white matter disease (NSWMD) using MRI scans. These AI tools can aid in diagnosing MS, improving patient evaluation and treatment.

Keywords:
MRIMachine learningartificial intelligenceimage classificationmultiple sclerosis

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.5K

Related Experiment Videos

Last Updated: Jul 6, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.0K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.5K

Area of Science:

  • Neurology
  • Radiology
  • Artificial Intelligence

Background:

  • Diagnosing multiple sclerosis (MS) often involves magnetic resonance imaging (MRI) and ruling out similar conditions.
  • Non-specific white matter disease (NSWMD) frequently mimics MS on MRI, complicating diagnosis.
  • Distinguishing MS from NSWMD can necessitate further tests or extended observation.

Purpose of the Study:

  • To develop and assess machine learning models for differentiating MS from NSWMD.
  • To improve the accuracy and efficiency of MS diagnosis using neuroimaging data.

Main Methods:

  • Adult patients (2015-2019) with brain MRI using a demyelinating protocol and available medical records were included.
  • Diagnoses of MS and NSWMD were confirmed via clinical documentation.
  • Logistic regression and convolutional neural network (CNN) models were trained on matched MS and NSWMD cases based on T2 lesion volume (T2LV).

Main Results:

  • 250 MS and 250 NSWMD MRI scans were analyzed, matched by T2LV.
  • A logistic regression model achieved 68.0% accuracy in differentiating MS from NSWMD using 20 variables.
  • CNN models demonstrated an average accuracy of 77% and 78% in independent validation and testing cohorts.

Conclusions:

  • Automated machine learning approaches can effectively distinguish MS from NSWMD on MRI.
  • These AI-driven methods offer supplementary diagnostic support for patients evaluated for MS.